NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1,212 Cr | ₹849 Cr | ₹47 Cr | ₹299 Cr | ₹417 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹1,212 Cr |
Mar2023 | ₹849 Cr |
Mar2022 | ₹47 Cr |
Mar2021 | ₹299 Cr |
Mar2020 | ₹417 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1,212 Cr | 42.69 | |
Mar2023 | ₹849 Cr | 1,726.02 | |
Mar2022 | ₹47 Cr | -84.44 | |
Mar2021 | ₹299 Cr | -28.40 | |
Mar2020 | ₹417 Cr | - |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹22,124.2 Cr | 6.4% | -6.9% | 35.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 6.4% |
-6.9% |
35.3% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses